We analyzed the correlation between CD47 expression and patient survival and evaluated the antitumor effect of macrophages against CD47-expressing RCC cells when CD47-blocking antibodies interrupted the interaction between CD47 and SIRPα. Here, SIRPA is linked to renal cell carcinoma.